Condition (MeSH)
Splenic Diseases
ClinicalTrials.gov lists 27 trials for Splenic Diseases or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 27 trials are tagged with Splenic Diseases itself; the rest are tagged with a narrower condition beneath it.
When did Splenic Diseases trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 7 |
| 2025 | 2 |
| 2024 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2014 | 2 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Splenic Diseases trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Not applicable | 11 |
| Observational | 13 |
How many Splenic Diseases trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 5 |
| Recruiting | 5 |
| Completed | 12 |
| Terminated | 1 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Splenic Diseases trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| EchoNous Inc. | 1 |
| Koneti Rao | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which drugs are being tested for Splenic Diseases? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Soquelitinib | 1 |
| Thyrogen | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Lumason® contrast agent | 1 |
| Vermurafenib | 1 |
| Beta Blocker | 1 |
| Apixaban IR | 1 |
| CT scan | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Splenic Diseases trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| low serum IgG | 1 | 1 |
| pneumomediastinum | 1 | 1 |
Which publications cover Splenic Diseases? (27)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Sarcopenia is a useful risk stratification tool to prognosticate splenic abscess patients in the emergency department. | Journal of the Formosan Medical Association = Taiwan yi zhi | 2021 | Yes |
| Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature. | PLoS neglected tropical diseases | 2021 | Yes |
| Insights into determinants of spleen injury in sickle cell anemia. | Blood advances | 2019 | Yes |
| Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. | Journal of hepatology | 2014 | Yes |
| Diffusion-weighted magnetic resonance imaging in the upper abdomen: technical issues and clinical applications. | Magnetic resonance imaging clinics of North America | 2011 | Yes |
Showing 5 of 27 publications.
Sub-conditions in MeSH (4)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.